Pfizer Launches Final Study For COVID Drug That’s Suspiciously Similar To #ivermectin
+
https://www.businesswire.com/news/home/20210323005644/en/Pfizer-Initiates-Phase-1-Study-of-Novel-Oral-Antiviral-Therapeutic-Agent-Against-SARS-CoV-2
In-vitro studies conducted to date show that the clinical candidate PF-07321332 is a potent protease inhibitor with potent anti-viral activity against SARS-CoV-2
#PF07321332
No comments:
Post a Comment